COMMENTARY
New (and Cheaper) HCV Therapy: Option for HIV Coinfection?
Paul E. Sax, MD
Hi. This is Dr Paul Sax, from Brigham and Women's Hospital and Harvard Medical School. Today I'd like to discuss the January approval in the area of hepatitis C virus (HCV) treatment—the single-tablet regimen containing elbasvir and grazoprevir—and in particular, how it relates to our patients coinfected with HIV..
View Video @ Medscape
No comments:
Post a Comment